Found: 54
Select item for more details and to access through your institution.
Metastasectomy following incomplete response to high‐dose interleukin‐2.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 4, p. 572, doi. 10.1002/jso.24916
- By:
- Publication type:
- Article
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1405, doi. 10.1007/s00262-022-03314-1
- By:
- Publication type:
- Article
The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2).
- Published in:
- Journal of Personalized Medicine, 2014, v. 4, n. 1, p. 52, doi. 10.3390/jpm4010052
- By:
- Publication type:
- Article
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 471, p. 1, doi. 10.1126/scitranslmed.aau0417
- By:
- Publication type:
- Article
Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 194, doi. 10.1186/1471-2407-11-194
- By:
- Publication type:
- Article
Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 12, p. 808, doi. 10.1038/sj.cgt.7700762
- By:
- Publication type:
- Article
Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma.
- Published in:
- Oncology, 2012, v. 84, n. 2, p. 123, doi. 10.1159/000342764
- By:
- Publication type:
- Article
Local IL-21 Promotes the Therapeutic Activity of Effector T cells by Decreasing Regulatory T Cells Within the Tumor Microenvironment.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 2, p. 380, doi. 10.1038/mt.2008.249
- By:
- Publication type:
- Article
Strategies for cancer therapy using carcinoembryonic antigen vaccines.
- Published in:
- Expert Reviews in Molecular Medicine, 2000, v. 2, n. 3, p. 1, doi. 10.1017/S146239940000168X
- By:
- Publication type:
- Article
Surgical factors affecting regionally metastatic cutaneous squamous cell carcinoma to the parotid gland.
- Published in:
- Head & Neck, 2023, v. 45, n. 5, p. 1080, doi. 10.1002/hed.27304
- By:
- Publication type:
- Article
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
- Published in:
- Head & Neck, 2016, v. 38, n. 12, p. 1752, doi. 10.1002/hed.24522
- By:
- Publication type:
- Article
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
- Published in:
- 2016
- By:
- Publication type:
- letter
TNF-α-induced activation of RhoA/Rho kinase pathway in human pulmonary microvascular endothelial cells.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A1201, doi. 10.1096/fasebj.21.6.a1201-c
- By:
- Publication type:
- Article
Management of Metastatic Melanoma to the Breast with High-Dose Interleukin-2 and Surgical Resection.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-113
- By:
- Publication type:
- Article
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-137
- By:
- Publication type:
- Article
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Poxvirus-based vaccine therapy for patients with advancedpancreatic cancer.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 60, doi. 10.1186/1479-5876-5-60
- By:
- Publication type:
- Article
Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma.
- Published in:
- Oncolytic Virotherapy, 2014, v. 3, p. 11, doi. 10.2147/OV.S36701
- By:
- Publication type:
- Article
Oncolytic virus therapy for cancer.
- Published in:
- Oncolytic Virotherapy, 2013, v. 2, p. 31, doi. 10.2147/OV.S38901
- By:
- Publication type:
- Article
Manipulating the Local Tumor Microenvironment with Poxviruses Expressing Costimulatory Molecules.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1062, n. 1, p. 41, doi. 10.1196/annals.1358.007
- By:
- Publication type:
- Article
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 685, doi. 10.1007/s00262-007-0407-z
- By:
- Publication type:
- Article
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 504
- By:
- Publication type:
- Article
Avelumab Immunotherapy: Management of adverse events associated with new treatment for Merkel cell carcinoma.
- Published in:
- Clinical Journal of Oncology Nursing, 2019, v. 23, n. 1, p. E1, doi. 10.1188/19.CJON.E1-E9
- By:
- Publication type:
- Article
Can Surgeons Expand the Role of Oncolytic Viruses for Cancer Treatment? An Editorial Comment on "Fighting Fire with Fire: Oncolytic Virotherapy in Thoracic Malignancies".
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2670, doi. 10.1002/cncr.35314
- By:
- Publication type:
- Article
Leiomyoma of the breast.
- Published in:
- Journal of Surgical Oncology, 1996, v. 62, n. 1, p. 62, doi. 10.1002/(SICI)1096-9098(199605)62:1<62::AID-JSO13>3.0.CO;2-V
- By:
- Publication type:
- Article
Talimogene Laherparepvec (T-VEC) as Cancer Immunotherapy.
- Published in:
- Personalized Medicine in Oncology, 2017, v. 6, n. 1, p. 21
- By:
- Publication type:
- Article
An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 6, p. 821, doi. 10.1007/s40257-020-00554-8
- By:
- Publication type:
- Article
Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 174, p. 1, doi. 10.1126/scitranslmed.3005127
- By:
- Publication type:
- Article
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colonystimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 7081, doi. 10.2147/OTT.S115245
- By:
- Publication type:
- Article
Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences.
- Published in:
- Patient, 2018, v. 11, n. 4, p. 439, doi. 10.1007/s40271-018-0301-0
- By:
- Publication type:
- Article
The contralateral sentinel node.
- Published in:
- Canadian Journal of Surgery, 2005, v. 48, n. 5, p. 416
- By:
- Publication type:
- Article
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Enterocutaneous fistula in cancer patients: Etiology, management, outcome, and impact on further treatment.
- Published in:
- American Surgeon, 1998, v. 64, n. 12, p. 1204
- By:
- Publication type:
- Article
Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 2, p. 241, doi. 10.1111/pcmr.12666
- By:
- Publication type:
- Article
Clinical Perineural Invasion and Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma.
- Published in:
- Laryngoscope, 2022, v. 132, n. 6, p. 1213, doi. 10.1002/lary.29953
- By:
- Publication type:
- Article
Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04344-8
- By:
- Publication type:
- Article
Clinical utility of cell-free DNA liquid biopsies in Merkel cell carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Synthetic biology: at the crossroads of genetic engineering and human therapeutics—a Keystone Symposia report.
- Published in:
- Annals of the New York Academy of Sciences, 2021, v. 1506, n. 1, p. 98, doi. 10.1111/nyas.14710
- By:
- Publication type:
- Article
Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 11, p. 2245, doi. 10.1007/s00432-018-2738-x
- By:
- Publication type:
- Article
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 3, p. 507, doi. 10.1093/ndt/gfaa372
- By:
- Publication type:
- Article
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01483
- By:
- Publication type:
- Article
Avelumab Demonstrates Efficacy Across All Subgroups in Metastatic Merkel Cell Carcinoma.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 40
- By:
- Publication type:
- Article
Talimogene Laherparepvec (T-VEC) as Cancer Immunotherapy.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 14
- By:
- Publication type:
- Article
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51722-x
- By:
- Publication type:
- Article
Recursive SVM biomarker selection for early detection of breast cancer in peripheral blood.
- Published in:
- BMC Medical Genomics, 2013, v. 6, n. Suppl 1, p. 1, doi. 10.1186/1755-8794-6-S1-S4
- By:
- Publication type:
- Article
Statistical methods on detecting differentially expressed genes for RNA-seq data.
- Published in:
- BMC Systems Biology, 2011, v. 5, n. Suppl 3, p. 1, doi. 10.1186/1752-0509-5-S3-S1
- By:
- Publication type:
- Article
Unleashing the therapeutic potential of oncolytic viruses.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article